Literature DB >> 8986501

Gitaloxin poisoning in a child.

S Hachimi-Idrissi1, L Corne, V Maes, J Ramet.   

Abstract

Gitaloxin is a digitalis glycoside used for the same indications as digoxin and digitoxin. The successful outcome for a 2 1/2-year-old boy who accidentally ingested 3 mg of gitaloxin (100 times the normal therapeutic dose) is reported. At admission the child presented with irregular heart rhythm. He subsequently started vomiting, even after continuous gastric feeding. Only 48 h after ingestion of gitaloxin he became somnolent and developed bradyarrhythmia. The symptoms disappeared 96 h later; the bradyarrhythmia, however, (second-degree atrioventricular block) decreased progressively only after 120 h. The initial clinical presentation of gitaloxin poisoning may be misleading and careful observation in a pediatric intensive care unit is mandatory. A cross-reaction between the fluorescence polarization immunoassay for digitoxin and the radioimmunoassay for gitaloxin was found and was used as a helpful, but rough, estimate of the severity of gitaloxin poisoning, in the absence of a specific measurement of gitaloxin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8986501     DOI: 10.1007/bf01709566

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  12 in total

1.  The sodium-potassium adenosine triphosphatase: pharmacological, physiological and biochemical aspects.

Authors:  A Schwartz; G E Lindenmayer; J C Allen
Journal:  Pharmacol Rev       Date:  1975-03       Impact factor: 25.468

2.  Recognition and management of digitalis intoxication: implications for emergency medicine.

Authors:  M J Bayer
Journal:  Am J Emerg Med       Date:  1991-03       Impact factor: 2.469

3.  The use of digoxin-specific Fab fragments for severe digitalis intoxication in children.

Authors:  A D Woolf; T Wenger; T W Smith; F H Lovejoy
Journal:  N Engl J Med       Date:  1992-06-25       Impact factor: 91.245

4.  [Preliminary study of the pharmacokinetics of gitaloxin in man].

Authors:  M Lesne; L Brasseur
Journal:  Arch Int Pharmacodyn Ther       Date:  1973-01

Review 5.  Digitalis glycosides: mechanisms and manifestations of toxicity. Part III.

Authors:  T W Smith; E M Antman; P L Friedman; C M Blatt; J D Marsh
Journal:  Prog Cardiovasc Dis       Date:  1984 Jul-Aug       Impact factor: 8.194

6.  Treatment of foxglove extract poisoning with digoxin-specific Fab fragments.

Authors:  S A Rich; J M Libera; R J Locke
Journal:  Ann Emerg Med       Date:  1993-12       Impact factor: 5.721

Review 7.  Digitalis cardiotoxicity.

Authors:  C Fisch; S B Knoebel
Journal:  J Am Coll Cardiol       Date:  1985-05       Impact factor: 24.094

8.  Digitalis glycosides.

Authors:  J F Bresnahan; R E Vlietstra
Journal:  Mayo Clin Proc       Date:  1979-10       Impact factor: 7.616

9.  Digoxin-specific Fab fragments in the treatment of oleander toxicity in a canine model.

Authors:  R F Clark; B S Selden; S C Curry
Journal:  Ann Emerg Med       Date:  1991-10       Impact factor: 5.721

10.  Oleander poisoning: treatment with digoxin-specific Fab antibody fragments.

Authors:  G M Shumaik; A W Wu; A C Ping
Journal:  Ann Emerg Med       Date:  1988-07       Impact factor: 5.721

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.